Market Research Logo

Profectus BioSciences, Inc. - Product Pipeline Review - 2016

Profectus BioSciences, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Profectus BioSciences, Inc. - Product Pipeline Review - 2016’, provides an overview of the Profectus BioSciences, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Profectus BioSciences, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Profectus BioSciences, Inc.
  • The report provides overview of Profectus BioSciences, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Profectus BioSciences, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Profectus BioSciences, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Profectus BioSciences, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Profectus BioSciences, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Profectus BioSciences, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Introduction
Global Markets Direct Report Coverage
Profectus BioSciences, Inc. Snapshot
Profectus BioSciences, Inc. Overview
Key Information
Key Facts
Profectus BioSciences, Inc. - Research and Development Overview
Key Therapeutic Areas
Profectus BioSciences, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Profectus BioSciences, Inc. - Pipeline Products Glance
Profectus BioSciences, Inc. - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Profectus BioSciences, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Profectus BioSciences, Inc. - Drug Profiles
(Ebola + Marburg) (monovalent) vaccine
Product Description
Mechanism of Action
R&D Progress
(Ebola + Marburg) (trivalent) vaccine
Product Description
Mechanism of Action
R&D Progress
HIV [strain C1086] vaccine
Product Description
Mechanism of Action
R&D Progress
HIV-1 vaccine
Product Description
Mechanism of Action
R&D Progress
IHV-001
Product Description
Mechanism of Action
R&D Progress
(nipah + hendra) vaccine
Product Description
Mechanism of Action
R&D Progress
chikungunya vaccine
Product Description
Mechanism of Action
R&D Progress
equine encephalitis vaccine
Product Description
Mechanism of Action
R&D Progress
hepatitis B vaccine
Product Description
Mechanism of Action
R&D Progress
hepatitis C vaccine
Product Description
Mechanism of Action
R&D Progress
human papillomavirus (7-valent) vaccine
Product Description
Mechanism of Action
R&D Progress
M-102.4
Product Description
Mechanism of Action
R&D Progress
herpes simplex virus 2 vaccine
Product Description
Mechanism of Action
R&D Progress
Lassa fever vaccine
Product Description
Mechanism of Action
R&D Progress
respiratory syncytial virus vaccine
Product Description
Mechanism of Action
R&D Progress
Profectus BioSciences, Inc. - Pipeline Analysis
Profectus BioSciences, Inc. - Pipeline Products by Target
Profectus BioSciences, Inc. - Pipeline Products by Route of Administration
Profectus BioSciences, Inc. - Pipeline Products by Molecule Type
Profectus BioSciences, Inc. - Recent Pipeline Updates
Profectus BioSciences, Inc. - Dormant Projects
Profectus BioSciences, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Profectus BioSciences, Inc., Key Information
Profectus BioSciences, Inc., Key Facts
Profectus BioSciences, Inc. - Pipeline by Indication, 2016
Profectus BioSciences, Inc. - Pipeline by Stage of Development, 2016
Profectus BioSciences, Inc. - Monotherapy Products in Pipeline, 2016
Profectus BioSciences, Inc. - Combination Treatment Modalities in Pipeline, 2016
Profectus BioSciences, Inc. - Partnered Products in Pipeline, 2016
Profectus BioSciences, Inc. - Partnered Products/ Combination Treatment Modalities, 2016
Profectus BioSciences, Inc. - Phase I, 2016
Profectus BioSciences, Inc. - Preclinical, 2016
Profectus BioSciences, Inc. - Discovery, 2016
Profectus BioSciences, Inc. - Pipeline by Target, 2016
Profectus BioSciences, Inc. - Pipeline by Route of Administration, 2016
Profectus BioSciences, Inc. - Pipeline by Molecule Type, 2016
Profectus BioSciences, Inc. - Recent Pipeline Updates, 2016
Profectus BioSciences, Inc. - Dormant Developmental Projects,2016
Profectus BioSciences, Inc., Other Locations
List of Figures
Profectus BioSciences, Inc. - Pipeline by Top 10 Indication, 2016
Profectus BioSciences, Inc. - Pipeline by Stage of Development, 2016
Profectus BioSciences, Inc. - Monotherapy Products in Pipeline, 2016
Profectus BioSciences, Inc. - Combination Treatment Modalities in Pipeline, 2016
Profectus BioSciences, Inc. - Pipeline by Top 10 Target, 2016
Profectus BioSciences, Inc. - Pipeline by Top 10 Molecule Type, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report